Aillis

Tokyo, Japan

Aillis is an AI-powered medical device for early and accurate influenza detection in the development of innovative medical devices.

$3.3M raised

Nov 2024

Series D

Top Investors

Nissay CapitalMITSUI SUMITOMO INSURANCE Venture Capital (MSIVC)Beyond Next VenturesPegasus Tech VenturesShionogi

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Aillis raised?

Aillis has raised $3.3M in total funding. The most recent round was Series D. The last funding was announced in November 2024.

Who are Aillis's investors?

Aillis's investors include Nissay Capital, MITSUI SUMITOMO INSURANCE Venture Capital (MSIVC), Beyond Next Ventures, Pegasus Tech Ventures, Shionogi.

Where is Aillis headquartered?

Aillis is headquartered in Tokyo, Japan.

What does Aillis do?

Aillis is an AI-powered medical device for early and accurate influenza detection in the development of innovative medical devices.

What stage is Aillis at?

Aillis is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 29, 2024.

MLA

"Aillis — Funding & Investors." VCBacked, November 29, 2024, https://www.vcbacked.co/company/aillis. Accessed June 4, 2026.

APA

VCBacked. (2024). Aillis — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/aillis

Wikipedia (cite web)

{{cite web |title=Aillis — Funding & Investors |url=https://www.vcbacked.co/company/aillis |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 29, 2024.